FUNDACION INSTITUTO DE INVESTIGACION MARQUES DE VALDECILLA

Their core work

IDIVAL is the biomedical research foundation of the Marqués de Valdecilla University Hospital in Santander, Spain — one of the country's major clinical research hubs. They conduct translational and clinical research, bridging hospital practice with structured scientific inquiry. Their EU project track record shows two specific capabilities: integrating and linking heterogeneous patient health records to extract clinical insight (HELICAL), and building data-driven platforms for early cardiovascular risk identification and patient-centred preventive care (TIMELY). In practice, they function as a clinical research partner that brings real patient data, cardiology expertise, and hospital infrastructure to European research consortia.

What they specialise in

How they've shifted over time

IDIVAL entered EU collaboration through HELICAL (2019), a Marie Skłodowska-Curie training network, contributing expertise in health record linkage — a foundational data infrastructure challenge. By 2021 they joined TIMELY, shifting from data linkage methodology toward clinical application: early risk prediction and prevention specifically in cardiovascular disease. The trajectory is clear: from building the plumbing (how to connect patient data) to using that plumbing for a specific clinical outcome (catching heart disease early). This is a coherent deepening, not a pivot.

IDIVAL is moving toward applied cardiovascular digital health — consortium builders working on chronic disease prediction, EHR-based risk stratification, or patient-centred prevention platforms will find an increasingly relevant clinical partner here.

How they like to work

IDIVAL has never led an H2020 project — in both cases they joined as partner or participant within larger consortia. Their 40 unique partners across 12 countries, drawn from just 2 projects, confirms they operate inside substantial multi-partner networks rather than tight bilateral arrangements. This suggests they are comfortable as a specialist contributor — providing clinical expertise, patient data access, or cardiology domain knowledge — rather than taking the administrative and coordination lead.

Despite only two projects, IDIVAL has touched 40 distinct consortium partners across 12 countries — a sign that both projects were large, multi-site European collaborations. Their network is genuinely pan-European rather than Iberian-focused.

What sets them apart

IDIVAL combines hospital-grade clinical infrastructure with structured research capacity in a way that pure universities or independent institutes cannot replicate — they can provide access to real patient cohorts, clinical validation environments, and cardiology specialists within a single foundation. For a consortium that needs a Spanish clinical site with cardiovascular and health data credentials, IDIVAL is one of relatively few hospital-anchored research entities in northern Spain with active EU project experience. Their specific combination of health record linkage know-how and preventive cardiology clinical work is a narrow but increasingly valuable niche as digital health projects multiply.

Highlights from their portfolio

• TIMELY
  Their only directly funded H2020 project (EUR 233,750), focused on a patient-centred cardiovascular risk prediction platform — the clearest signal of where IDIVAL's applied clinical capabilities are being deployed.
• HELICAL
  A Marie Skłodowska-Curie ITN training network on health data linkage, notable because it placed IDIVAL inside a research-excellence consortium and established their credentials in clinical informatics before their cardiology work.